CCCC
C4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.94 / 10
Underperform
Technical analysis is poor (1.94/10) with three bearish indicators—Long Lower Shadow, Marubozu White, and MACD Death Cross—dominating. Recent patterns suggest a weak market state and a potential decline, warranting caution.
Analysis Checks(0/3)
Long Lower Shadow
Score1.24/10
Win Rate40.30%
Hist. Signals67
Avg Return-0.61%
Score1.24/10
Win Rate40.30%
Hist. Signals67
Avg Return-0.61%
Marubozu White
Score3.58/10
Win Rate45.00%
Hist. Signals20
Avg Return2.69%
Score3.58/10
Win Rate45.00%
Hist. Signals20
Avg Return2.69%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-5.76%
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-5.76%
Long Lower Shadow
Score1.24/10
Win Rate40.30%
Hist. Signals67
Avg Return-0.61%
Score1.24/10
Win Rate40.30%
Hist. Signals67
Avg Return-0.61%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-5.76%
Score1/10
Win Rate25.00%
Hist. Signals12
Avg Return-5.76%
Marubozu White
Score3.58/10
Win Rate45.00%
Hist. Signals20
Avg Return2.69%
Score3.58/10
Win Rate45.00%
Hist. Signals20
Avg Return2.69%
What is the current technical signals for CCCC?
- CCCC presents a Underperform setup with a Technical Score of 1.94/10. Key technical indicators highlight an RSI of 39.35 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 2.21. Traders should monitor key support at 1.63 and resistance at 1.85.
